Titrating Critical Care Medications

Similar documents
Vasoactive Medications. Matthew J. Korobey Pharm.D., BCCCP Critical Care Clinical Specialist Mercy St. Louis

The Pharmacology of Hypotension: Vasopressor Choices for HIE patients. Keliana O Mara, PharmD August 4, 2018

Swans and Pressors. Vanderbilt Surgery Summer School Ricky Shinall

Swans and Pressors. Vanderbilt Surgery Summer School Ricky Shinall

Case year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

Intravenous Infusions

DIAGNOSIS AND MANAGEMENT OF ACUTE HEART FAILURE

Clinical Competency Name: Post-operative use of Metaraminol in Recovery

Adenosine. poison/drug induced. flushing, chest pain, transient asystole. Precautions: tachycardia. fibrillation, atrial flutter. Indications: or VT

Bolus (Push Dose) Pressors: Good Idea or a bit Much?

VASOPRESSORS AND INOTROPES CLINICAL PROFESSOR ANDREW BEZZINA FACEM MAY 2017

Norepinephrine (Levophed )

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments

Hemodynamic Monitoring and Circulatory Assist Devices

Cardiovascular Management of Septic Shock

6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center

Shock and Vasopressors. Nina E. Glass, MD TACS Fellow SICU Didactic Curriculum 9/24/14

HOW LOW CAN YOU GO? HYPOTENSION AND THE ANESTHETIZED PATIENT.

PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker

Useful diagnostic measures: chest x ray to check pulmonary edema, ECG and ECHO to detect cardiac abnormalities (1).

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

SHOCK AETIOLOGY OF SHOCK (1) Inadequate circulating blood volume ) Loss of Autonomic control of the vasculature (3) Impaired cardiac function

Nothing to Disclose. Severe Pulmonary Hypertension

Adult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES

Systemic Pharmacology Lecture 7: Neuropharmacology

The Art and Science of Infusion Nursing John M. Allen, PharmD, BCPS. Understanding Vasoactive Medications

When Fluids are Not Enough: Inopressor Therapy

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Pharmacology of inotropes and vasopressors

Hypotension in the Neonate

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

HYPOTENSION IS DANGEROUS C. R Y A N K E A Y, M D, F A C E P 1 6 M A R C H

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

Michigan EMS. Medication In-Service: Push Dose Epinephrine. Instructor Resource Guide. Format: Lecture

Objectives: This presentation will help you to:

BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1

ALS MODULE 7 Pharmacology

WHAT DO YOU SEE WHEN YOU STIMULATE BETA

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

7/4/2015. Titrating Vasoactive Drips

MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa

Sepsis: Identification and Management in an Acute Care Setting

Critical Care Medication Administration

Admission of patient CVICU and hemodynamic monitoring

Sepsis Management: Past, Present, and Future

-Cardiogenic: shock state resulting from impairment or failure of myocardium

Surviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

Utilizing Vasopressors:

Adrenergic Agonists 1

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Neosynephrine. Name of the Medicine

The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic

SEPSIS RAPID RESPONSE

การอบรมว ทยาศาสตร พ นฐานทางศ ลยศาสตร เร อง นพ.ส ณฐ ต โมราก ล ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร โรงพยาบาลรามาธ บด มหาวทยาลยมหดล

Contra Costa County Emergency Medical Services Drug Reference. Indication Dosing Cautions Comments

Relax and Learn At the Farm 2012

Adult Critical Care Intravenous Infusions Titration Protocol

John Park, MD Assistant Professor of Medicine

12/1/2009. Chapter 19: Hemorrhage. Hemorrhage and Shock Occurs when there is a disruption or leak in the vascular system Internal hemorrhage

Staging Sepsis for the Emergency Department: Physician

Weeks 1-3:Cardiovascular

Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide

PRESCRIBING INFORMATION LEVOPHED. (norepinephrine bitartrate injection USP) 1 mg norepinephrine/ ml

Heart Failure (HF) Treatment

The Hypotensive Poisoned Patient. Robert S. Hoffman, MD Director, NYC PCC

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Pheochromocytoma: Effects of Catecholamines

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

Dilemmas in Septic Shock

Medical Management of Acutely Decompensated Heart Failure. William T. Abraham, MD Director, Division of Cardiovascular Medicine

Pediatric Sepsis Treatment:

Dr Nick Taylor Visiting Emergency Specialist Teaching Hospital Karapitiya

Physiological Response to Hypovolemic Shock Dr Khwaja Mohammed Amir MD Assistant Professor(Physiology) Objectives At the end of the session the

Failure of the circulation to maintain Tissue cellular. Tissue hypoperfusion Cellular hypoxia SHOCK. Perfusion

When Fluids are Not Enough: Inopressor Therapy

Shock Quiz! By Clare Di Bona

Low Cardiac Output in the Pediatric Patient

Nurse Driven Fluid Optimization Using Dynamic Assessments

VASOACTIVE DRUGS AND THEIR USE IN SHOCK. Learning Objectives. Shock 10/5/2016

Pediatric Septic Shock. Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee

Sepsis is a complicated infectious process that propagates. Use of Vasopressors in Septic Shock. Clinical review

MANAGEMENT OF CIRCULATORY FAILURE

Management of Severe Sepsis:

Vasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada

SUMMARY OF PRODUCT CHARACTERISTICS

Vasoactive drugs. Dr. Zohair Alaseri, MD

Special circulations, Coronary, Pulmonary. Faisal I. Mohammed, MD,PhD

DOBUTamine INJECTION, USP R x only

Blood Pressure Fox Chapter 14 part 2

Means failure of heart to pump enough blood to satisfy the need of the body.

Post Cardiac Arrest Care 2015 American Heart Association Guideline Update for CPR and Emergency Cardiovascular Care

Cardiorenal and Renocardiac Syndrome

Emergency Cardiovascular Care: EMT-Intermediate Treatment Algorithms. Introduction to the Algorithms

Hemodynamic Monitoring

ANTI - ARRHYTHMIC DRUGS

Vasopressors in septic shock

Transcription:

Titrating Critical Care Medications Chad Johnson, MSN (NED), RN, CNCC(C), CNS-cc Clinical Nurse Specialist: Critical Care and Neurosurgical Services E-mail: johnsoc@tbh.net Copyright 2017 1

Learning Objectives The participant will be able to: 1. Determine when vasoactive medications are indicated. 2. Describe parameters and titration of critical care medications. 3. Define titration, vasopressor, inotropes, catecholamine, and adrenergic. 4. Identify vasoactive drugs, infusion rates, and other medications used to treat the critically ill patient. 5. Describe how to safely administer medications requiring titration. 2

Definitions Titration: increasing or decreasing a vasoactive drug or other critical infusion for therapeutic effect. Vasopressor: a class of drugs that induce arteriole vasoconstriction and thereby elevate blood pressure. Inotropes: drugs that affect the strength of contraction of heart muscle (myocardial contractility); negative inotropes (beta-blockers, diltiazem, and verapamil) decrease cardiac workload and blood pressure, positive inotropes (dopamine, dobutamine, epinephrine and norepinephrine) increase cardiac workload and blood pressure. Catecholamine: any of a class of aromatic amines that includes a number of neurotransmitters which cause sympathomimetic action (epinephrine, norepinephrine, dopamine, dobutamine). Adrenergic: having characteristics of secreting epinephrine or substances with similar activity (epinephrine and norepinephrine). 3

Indications Systolic blood Pressure (SBP) has a decrease of > 30 mm Hg from the baseline or a mean arteriole pressure (MAP) less than 65 mm Hg and when either condition results in end-organ dysfunction due to hypoperfusion. Pump: problem with the heart (MI, arrhythmia). Volume: circulating volume (hypovolemic shock). Squeeze: how tight or constricted the arterial system is (septic shock). 4

Receptors Receptors Location Action Alpha adrenergic: Alpha-1 Vascular walls (arteries) Heart Beta adrenergic Beta-1 Heart Vasoconstriction Increase the duration of contraction without increasing chronotropy (heart rate) Increase inotropy (force of contraction) and chronotropy (heart rate) with minimal vasocontriction Beta-2 Blood vessels in the lungs Vasodilation and brochodilation 5

Dopamine 1 to 2 mcg per kg per minute Dopamine stimulates dopaminergic receptors in the renal bed, dilates renal arteries, and increases renal blood flow and increases urine production. 5 to 10 mcg per kg per minute Greater than 10 mcg per kg per minute Dopamine stimulates beta-1 receptors in the heart. This increases in contractility and heart rate (which in turn will increase CO and usually blood pressure). At this dose the medication acts more as a positive inotrope. Dopamine stimulates alpha receptors in the peripheral vasculature, causing vasoconstriction and an increase in SVR, thus increasing blood pressure. The dose-dependent effects of dopamine mean that increasing the dose of the medication is similar to switching vasopressors. 6

Dopamine The usual dosage range for dopamine is 2 to 20 mcg per kg per minute by continuous IV infusion, onset occurs within 5 minutes, peak time is unknown, and duration of its action lasts about 10 minutes after discontinuation. American Heart Association (AHA, 2015) guidelines recommend dopamine as the second drug of choice after atropine to treat symptomatic bradycardia. Nursing implications: Before administering, correct hypovolemia and establish goal blood pressure. Monitor blood pressure, heart rate and rhythm every five minutes during titration. Monitor for tachyarrhythmias. Infuse by central line if possible; if peripheral, monitor IV site routinely for extravasation. Treat suspected infiltrations with phentolamine. Consider alternate medication if at about 20 mcg per kg per minute goal blood pressure is not reached. 7

Phentolamine for Extravasation Uses: Medication of choice in to control blood pressure and sweating caused by pheochromocytoma, an epinephrine-secreting tumor that can arise from the adrenal medulla. Treat the extravasation of vasopressors into peripheral tissues (e.g., dobutamine, dopamine, epinephrine, norepinephrine, phenylephrine, and vasopressin). Dose: 5 mg is diluted in 10 ml normal saline and administered S/C into the infiltrated area as soon as possible following the extravasation (within 12-hours). If dose effective, normal skin colour should return to the blanched area within one hour. Elevate affected limb for 24 to 48-hours. Apply local warming therapy for 15 to 20 minutes, every 4-hours for 24 to 48-hours. 8

Phentolamine Policy 9

Norepinephrine Affects alpha receptors causing peripheral vasoconstriction, increased blood pressure, and increased SVR. The dosage is 0.01 to 0.3 mcg per kg per minute by continuous IV infusion, onset and peak time are immediate with 1 to 2 minute duration of effect when infusion is turned off. First-choice vasopressor for sepsis (Surviving Sepsis Campaign, 2016). Nursing implications: Before administering, correct hypovolemia and establish goal blood pressure. Monitor blood pressure, heart rate, and rhythm every five minutes during titration. Infuse by central line if possible; if peripheral, monitor IV site routinely for extravasation. Treat suspected infiltrations with phentolamine. Do not mix with NS. Do not mix with alkaline agents (those with a ph greater than 6.0, such as sodium bicarbonate, lidocaine and aminophylline). Monitor for headache, nausea, and vomiting, bradycardia, chest pain, and hypertension. Higher doses may be needed if receptors are down-regulated, as in sepsis. Very effective in low-svr; less effect on heart rate than dopamine; preferred in presence of tachyarrhythmia. 10

Phenylephrine Often used for cardiac patients because of its pure alpha-receptor activity: it is less likely to cause tachyarrhythmias and will increase SVR, with a resultant increase in mean arterial pressure (MAP). The dosage is 0.5 to 5 mcg per kg per minute by continuous IV infusion, IV onset is immediate, peak time is unknown, and duration is 15 to 20 minutes duration of effect when infusion is turned off. Phenylephrine may also be given in intermittent IV bolus doses to support blood pressure. Dilute phenylephrine 10 mg in 100 ml of NS for a final concentration of 100 mcg/ml. Nursing implications: Before administering, correct hypovolemia and establish goal blood pressure. Monitor blood pressure, heart rate, and rhythm every five minutes during titration. Infuse by central line if possible; if peripheral, monitor IV site routinely for extravasation. Treat suspected infiltrations with phentolamine. Adverse effects may include bradycardia, hypertension, anxiety, tremor and arrhythmia. Phenylephrine is not a first-line pressor for treating septic shock (Surviving Sepsis Campaign, 2016). 11

Vasopressin a.k.a. antidiuretic hormone = retain water in the body and constrict blood vessels (stimulation of V1 receptors causes vasoconstriction). Add to norepinephrine in patients with sepsis to achieve hemodynamic parameters. AHA (2015) guidelines no longer recommend in cardiac arrest. Onset of action in the presence of septic shock is within 15 minutes. Data are not available regarding the duration of action and peak effects when used in septic shock. Nursing implications: Establish goal blood pressure and monitor vital signs every 15 minutes the first hour, then at least hourly. Monitor serum sodium for the development of hyponatremia. Water retention is an innate characteristic of the drug and can cause decreased levels of consciousness and seizures caused by cerebral swelling if sodium levels are not maintained. 12

General Recommendations Vasoactive medications should be titrated to clinical endpoints (parameters) that are appropriate to the specific medication. Parameters for vasopressor medications include blood pressure (MAP), signs of adequate tissue perfusion (urinary output, mental status, skin perfusion, SvO 2, lactate levels) and/or related hemodynamic data (CO, SVR, CVP, pulmonary capillary wedge pressure), if accessible. Increase the dose until the clinical effect is achieved (usually effects are seen within minutes) use the peak effect of the medication to aid in increasing and decreasing infusion as tolerated. Notify the physician of potentially serious side effects or complications and titrate downward or discontinue the medication, if warranted. 13

Strategies for Safe Administration Hang a bag of NS with tubing on an infusion pump; set at a fixed rate. Use the shortest IV tubing and connect the IV line to the lowest port on the flush line. Always have a medication line in case of emergency. Clinical parameters (i.e., MAP, heart rate, etc.). Label IV lines Check infusions at the start of each shift Monitor the patient carefully. Become familiar with length of the catheter and IV tubing Attempt to wean infusions slowly. 14

Questions? 15